{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:08:52Z","timestamp":1790096932516,"version":"4.0.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2005,10,10]],"date-time":"2005-10-10T00:00:00Z","timestamp":1128902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2005,10,10]],"date-time":"2005-10-10T00:00:00Z","timestamp":1128902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1111\/j.1365-2133.2005.06932.x","type":"journal-article","created":{"date-parts":[[2005,10,10]],"date-time":"2005-10-10T08:19:25Z","timestamp":1128932365000},"page":"72-78","source":"Crossref","is-referenced-by-count":56,"title":["Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial"],"prefix":"10.1093","volume":"154","author":[{"given":"T.","family":"Ooi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.StC.","family":"Barnetson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"McKane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.B.","family":"Slade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,10,10]]},"reference":[{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4049\/jimmunol.127.4.1707","article-title":"Antigen presentation by murine epidermal Langerhans cells and its alteration by ultraviolet B light","volume":"127","author":"Stingl","year":"1981","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/82782","article-title":"Immune suppression and skin cancer development: regulation of NKT cells","volume":"1","author":"Moodycliffe","year":"2000","journal-title":"Nat Immunol"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2005.06932.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1067\/mjd.2000.103344","article-title":"Histopathology of incipient intraepidermal squamous cell carcinoma (\u2018actinic keratosis\u2019)","volume":"42","author":"Cockerell","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"i","author":"Marks","year":"1988","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.1986.tb06644.x","article-title":"Spontaneous remission of solar keratoses: the case for conservative management","volume":"115","author":"Marks","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0190-9622(97)70265-2","article-title":"Actinic keratoses","volume":"36","author":"Callen","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00403-003-0435-2","article-title":"High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population","volume":"295","author":"Pfister","year":"2003","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB8|cit8","first-page":"533","article-title":"Importance of human papillomaviruses for the development of skin cancer","volume":"25","author":"Meyer","year":"2001","journal-title":"Cancer Detect Prev"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2133.1994.tb08544.x","article-title":"Epidemiology of solar keratoses","volume":"131","author":"Frost","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.2188\/jea.9.6sup_7","article-title":"Sun exposure, skin cancers and related skin conditions","volume":"9","author":"Green","year":"1999","journal-title":"J Epidemiol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1067\/mjd.2000.103343","article-title":"Clinical presentation of actinic keratoses and squamous cell carcinoma","volume":"42","author":"Moy","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1346-8138.1995.tb03935.x","article-title":"The epidemiology of non-melanoma skin cancer: who, why and what can we do about it","volume":"22","author":"Marks","year":"1995","journal-title":"J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1468-3083.1998.tb00710.x","article-title":"Advances in the understanding of malignant transformation of keratinocytes: an immunohistochemical study","volume":"10","author":"Tucci","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB14|cit14","first-page":"583","article-title":"Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin","volume":"6","author":"Einspahr","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1034\/j.1600-0781.2002.180307.x","article-title":"Photoimmunosuppression","volume":"18","author":"Schwarz","year":"2002","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2003.12.010","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials","volume":"50","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0008-8749(02)00517-8","article-title":"Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod","volume":"218","author":"Gibson","year":"2002","journal-title":"Cell Immunol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2002.126257","article-title":"Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open-label trial","volume":"47","author":"Salasche","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/archderm.138.11.1498","article-title":"A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses","volume":"138","author":"Stockfleth","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2004.02.022","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology","volume":"51","author":"Sziemies","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1523-1747.2000.00833.x","article-title":"Imiquimod, a topical immune response modifier, induces migration of Langerhans cells","volume":"114","author":"Suzuki","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni758","article-title":"Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway","volume":"3","author":"Hemmi","year":"2002","journal-title":"Nat Immunol"},{"issue":"Suppl. 66","key":"10.1111\/j.1365-2133.2005.06932.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.0366-077X.2003.05628.x","article-title":"Imiquimod: modes of action","volume":"149","author":"Sauder","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/1523-1747.ep12347944","article-title":"Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance","volume":"106","author":"Schwarz","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/1523-1747.ep12479662","article-title":"Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma","volume":"97","author":"Tefany","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/jlb.58.3.365","article-title":"Cytokine induction by the immunomodulators imiquimod and S-27609","volume":"58","author":"Testerman","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.20020207","article-title":"Interferon and interleukin-12 are induced differentially by toll-like receptor 7 ligands in human blood dendritic cell subsets","volume":"195","author":"Ito","year":"2002","journal-title":"J Exp Med"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/S0923-1811(98)84074-7","article-title":"Effects of the imidazoquinolines, imiquimod and S-28463, on Th1 and Th2 cytokine responses in vitro","volume":"16","author":"Tomai","year":"1998","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2230.2004.01614.x","article-title":"Imiquimod-induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells","volume":"29","author":"Barnetson","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2230.2004.01593.x","article-title":"Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarized lymphoid and monocyte\/macrophage populations to a Th1 and M1 cytokine pattern","volume":"29","author":"Smith","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1067\/mjd.2001.111335","article-title":"Imiquimod 5% cream in the treatment of Bowen's disease","volume":"44","author":"Mackenzie-Wood","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/djg016","article-title":"Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod","volume":"95","author":"Schon","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl. 66","key":"10.1111\/j.1365-2133.2005.06932.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.0366-077X.2003.05632.x","article-title":"Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures","volume":"149","author":"Meyer","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06932.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1365-2133.2004.06094.x","article-title":"Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis","volume":"151","author":"Vidal","year":"2004","journal-title":"Br J Dermatol"},{"issue":"Suppl. 66","key":"10.1111\/j.1365-2133.2005.06932.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.0366-077X.2003.05634.x","article-title":"Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle","volume":"149","author":"Berman","year":"2003","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2005.06932.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2005.06932.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T21:14:58Z","timestamp":1706649298000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/154\/1\/72\/6636561"}},"subtitle":["Imiquimod-induced regression of actinic keratosis"],"short-title":[],"issued":{"date-parts":[[2005,10,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06932.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10,10]]}}}